Haleon Hopes Pathbreaking Eroxon Will ‘Resonate’ With US ED Sufferers
Executive Summary
October will see the bricks-and-mortar launch of the first FDA-approved OTC treatment for erectile dysfunction in the US by Haleon. HBW Insight catches up with the company's North America president Lisa Paley to find out what Haleon has planned for Eroxon's arrival in stores.